Eye tech incubator spins out third opthalmic company
This article was originally published in Clinica
Executive Summary
ForSight Labs, an incubator company focused on ophthalmic technologies, has raised $6m in series A funding for its newly-formed third venture, ForSight VISION3. Participants in the financing round include Morgenthaler Ventures, Split Rock Partners and Versant Ventures. ForSight said it is currently assessing which the technologies that VISION3 will work on. The other two companies created by Menlo Park, California-based ForSight are Transcend Medical, which is focused on devices for managing glaucoma, and ForSight Newco II, which is developing a proprietary punctual plug drug delivery system. The latter was acquired by QLT in October 2007.